Live Nasdaq Composite: Tech Stocks Slump as AI Costs Rise
Tech stocks lead a broad market pullback as AI costs rise and Netflix guidance misses, sending the Nasdaq Composite l...
Investing News
Investing News tag page curates 4 recent stories on stock moves, energy headlines, and live market updates. See how these developments could impact your portfolio and help refine your strategy.
21 articles
Marvell Crashed Below $200: Analyst Sees Potential to Double
Marvell Technology slides below the $200 level as cloud capex headlines shake sentiment. A KeyBanc upgrade to a $400 ...
QQQI Holders Left $7.63: Nasdaq Income ETF Faces Tradeoff
The NEOS QQQI ETF paid out $7.63 per share in the last 12 months, yet the fund trailed the Nasdaq-100 rally as invest...
Global Stocks Stage Rally as U.S. Markets Pause for Holiday
Global stocks stage rally across Europe and Asia as U.S. markets pause for a July 4 holiday, lifting risk appetite am...
Lucid Near All-Time Crucial Level Triggers Dilution Risks
Lucid's stock sits near a critical pricing zone as its balance sheet frays and dilution fears mount, even as producti...
Price Prediction: Will Broadcom Reach $500 This Year?
Broadcom delivered solid quarterly results, but AI guidance disappointed some investors, sending shares lower. Analys...
Live Nasdaq Composite: AI Stocks Reclaim Ground Today
AI-led tech names lead a Nasdaq rebound as volatility subsides and oil prices pull back. Here are the latest numbers,...
Cross-Border Workers Missing Thousands: Why It Matters
A little-known U.S.-Canada totalization treaty lets cross-border workers pool credits for retirement, but missteps in...
Amazon’s Hits Fastest Growth as AI Push Accelerates Cloud Bet
Amazon’s cloud powerhouse AWS posted its strongest growth in more than three years, as AI infrastructure investments ...
NVDL Lost Percent Early: Daily Reset Bleeds Leveraged ETF
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Figma Price Prediction: Stock Could Pop 125% This Year
Figma stock shows signs of a potential rebound as profitability improves and AI-driven features gain traction, even a...